These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
735 related items for PubMed ID: 22932115
1. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Matignon M, Muthukumar T, Seshan SV, Suthanthiran M, Hartono C. Transplantation; 2012 Sep 27; 94(6):603-11. PubMed ID: 22932115 [Abstract] [Full Text] [Related]
2. The impact of C4d staining as a humoral injury marker. Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI. Transplant Proc; 2012 Sep 27; 44(6):1694-6. PubMed ID: 22841245 [Abstract] [Full Text] [Related]
3. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection. Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA. Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1435-43. PubMed ID: 26071493 [Abstract] [Full Text] [Related]
5. Acute cellular rejection: impact of donor-specific antibodies and C4d. Willicombe M, Roufosse C, Brookes P, McLean AG, Galliford J, Cairns T, Cook TH, Taube D. Transplantation; 2014 Feb 27; 97(4):433-9. PubMed ID: 24430742 [Abstract] [Full Text] [Related]
6. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure. Malheiro J, Santos S, Tafulo S, Dias L, Martins S, Fonseca I, Almeida M, Pedroso S, Beirão I, Castro-Henriques A, Cabrita A. Transplantation; 2018 Nov 27; 102(11):1943-1954. PubMed ID: 29757900 [Abstract] [Full Text] [Related]
7. C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis? Neves M, Cotovio P, Machado S, Santos L, Macário F, Alves R, Pratas J, Xavier da Cunha M, Mota A, Campos M. Transplant Proc; 2012 Oct 27; 44(8):2360-5. PubMed ID: 23026593 [Abstract] [Full Text] [Related]
8. Long-term kidney allograft survival in patients with transplant glomerulitis. Nabokow A, Dobronravov VA, Khrabrova M, Gröne HJ, Gröne E, Hallensleben M, Kieneke D, Weithofer P, Smirnov AV, Kliem V. Transplantation; 2015 Feb 27; 99(2):331-9. PubMed ID: 25594551 [Abstract] [Full Text] [Related]
9. Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement. Zhao X, Huang G, Randhawa S, Zeng G, Lunz J, Randhawa P. Transplantation; 2017 Feb 27; 101(2):395-401. PubMed ID: 26901079 [Abstract] [Full Text] [Related]
10. Expression patterns of B cells in acute kidney transplant rejection. Carpio VN, Noronha Ide L, Martins HL, Jobim LF, Gil BC, Külzer AS, Loreto Mda S, Gonçalves LF, Manfro RC, Veronese FV. Exp Clin Transplant; 2014 Oct 27; 12(5):405-14. PubMed ID: 25299368 [Abstract] [Full Text] [Related]
11. Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience. Tatar E, Uslu A, Simsek C, Vardar E. Exp Clin Transplant; 2015 Apr 27; 13 Suppl 1():259-62. PubMed ID: 25894167 [Abstract] [Full Text] [Related]
12. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection. Tower CM, Reyes M, Nelson K, Leca N, Kieran N, Muczynski K, Jefferson JA, Blosser C, Kukla A, Maurer D, Chandler W, Najafian B. Transplantation; 2017 Sep 27; 101(9):2235-2243. PubMed ID: 27846156 [Abstract] [Full Text] [Related]
13. Renal allograft C4d deposition in Chinese: Hong Kong perspective. Yuen SK, Mak YF, Tang HL, Yong SP, Chow KM, Chu KH, Fung KS, Chan WH, Tong KL. Nephrology (Carlton); 2008 Jun 27; 13(3):256-63. PubMed ID: 18315707 [Abstract] [Full Text] [Related]
14. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, Böhmig GA. Trials; 2014 Apr 03; 15():107. PubMed ID: 24708575 [Abstract] [Full Text] [Related]
17. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure. Wang R, Wang H, Chen J, Wu J, Wang Y, Huang H, He Q. Nephrology (Carlton); 2009 Aug 03; 14(5):527-32. PubMed ID: 19674321 [Abstract] [Full Text] [Related]
18. C4d-negative antibody-mediated rejection in renal allografts: evidence for its existence and effect on graft survival. Haas M. Clin Nephrol; 2011 Apr 03; 75(4):271-8. PubMed ID: 21426880 [Abstract] [Full Text] [Related]
19. Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients. Djamali A, Muth BL, Ellis TM, Mohamed M, Fernandez LA, Miller KM, Bellingham JM, Odorico JS, Mezrich JD, Pirsch JD, D'Alessandro TM, Vidyasagar V, Hofmann RM, Torrealba JR, Kaufman DB, Foley DP. Kidney Int; 2013 Jun 03; 83(6):1185-92. PubMed ID: 23447068 [Abstract] [Full Text] [Related]
20. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA. Transpl Immunol; 2012 Jan 03; 26(1):62-9. PubMed ID: 21907804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]